HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuxiang Chen Selected Research

Nasopharyngeal Carcinoma

4/2020Author Correction: Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways.
1/2020Author Correction: Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
1/2019EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7.
2/2017Inhibition of store-operated Ca2+ entry counteracts the apoptosis of nasopharyngeal carcinoma cells induced by sodium butyrate.
8/2016CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.
7/2015Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways.
7/2015Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
4/2015Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
4/2005Calcium phosphate nanoparticles as a novel nonviral vector for efficient transfection of DNA in cancer gene therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuxiang Chen Research Topics

Disease

35Neoplasms (Cancer)
01/2022 - 12/2006
9Neoplasm Metastasis (Metastasis)
04/2020 - 07/2008
9Nasopharyngeal Carcinoma
04/2020 - 04/2005
9Colonic Neoplasms (Colon Cancer)
11/2017 - 07/2008
5Hepatocellular Carcinoma (Hepatoma)
09/2016 - 11/2010
4Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 01/2014
4Ovarian Neoplasms (Ovarian Cancer)
06/2014 - 10/2012
3Fibrosis (Cirrhosis)
03/2022 - 01/2021
3Lung Neoplasms (Lung Cancer)
01/2020 - 05/2012
3Stomach Neoplasms (Stomach Cancer)
05/2015 - 12/2006
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2013 - 08/2012
2Demyelinating Diseases (Demyelinating Disease)
01/2022 - 01/2022
2Bacterial Infections (Bacterial Infection)
01/2022 - 12/2021
2Type 2 Diabetes Mellitus (MODY)
01/2016 - 09/2012
2Carcinoma (Carcinomatosis)
06/2014 - 12/2011
2Lymphatic Metastasis
06/2013 - 07/2008
2Liver Neoplasms (Liver Cancer)
10/2012 - 11/2010
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022
1Neuroinflammatory Diseases
01/2022
1Edema (Dropsy)
01/2022
1Esophageal Achalasia (Megaesophagus)
01/2022
1Gastroesophageal Reflux (GERD)
01/2022
1Hyperemia
01/2022
1Spinal Cord Injuries (Spinal Cord Injury)
01/2022
1Reperfusion Injury
01/2022
1Rupture
12/2021
1Congenital Abnormalities (Deformity)
11/2021
1Kyphosis
11/2021
1Microsatellite Instability
07/2021
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2021
1Inflammation (Inflammations)
01/2021
1Acute Pain
01/2021
1Leukemia
01/2021
1Vascular Remodeling
02/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2020
1Adenocarcinoma of Lung
01/2020
1Wounds and Injuries (Trauma)
12/2018
1Osteoporosis
11/2016
1Hemolysis
06/2016
1Postoperative Nausea and Vomiting (PONV)
03/2016

Drug/Important Bio-Agent (IBA)

15MicroRNAs (MicroRNA)IBA
08/2020 - 11/2011
11Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2011
7Paclitaxel (Taxol)FDA LinkGeneric
11/2013 - 05/2011
4Small Interfering RNA (siRNA)IBA
01/2022 - 07/2008
4Biomarkers (Surrogate Marker)IBA
11/2017 - 05/2014
4calcium phosphateIBA
05/2015 - 12/2006
4Messenger RNA (mRNA)IBA
07/2014 - 07/2008
4DNA (Deoxyribonucleic Acid)IBA
05/2014 - 12/2006
3Biological ProductsIBA
01/2022 - 12/2012
3Caspase 3 (Caspase-3)IBA
01/2022 - 11/2011
3mouse MIRN29 microRNAIBA
06/2014 - 02/2012
3ProdrugsIBA
01/2009 - 04/2005
2EphA1 Receptor (Eph Receptor)IBA
01/2022 - 01/2022
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2021
2LigandsIBA
07/2021 - 01/2016
2flotillinsIBA
04/2020 - 07/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2020 - 12/2011
2TensinsIBA
06/2016 - 05/2012
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2016 - 05/2012
2SolutionsIBA
06/2016 - 10/2011
2matrigelIBA
07/2015 - 02/2014
2Pharmaceutical PreparationsIBA
05/2015 - 07/2008
2Liposomes (Liposome)IBA
05/2015 - 10/2011
2MethyltransferasesIBA
05/2014 - 12/2012
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
03/2022
1lysophosphatidic acidIBA
03/2022
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2022
1indoleIBA
01/2022
1EphA4 ReceptorIBA
01/2022
1diamidino compound 253-50IBA
01/2022
1EverolimusFDA Link
01/2022
1salicylhydroxamic acid (SHAM)IBA
01/2022
1Ephrin-A4 (Ephrin A4)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
07/2021
1C-Reactive ProteinIBA
01/2021
1AlbuminsIBA
01/2021
1NucleosidesIBA
01/2021
1pyridineIBA
01/2021
12,4-diaminopyrimidineIBA
10/2020
1AntagomirsIBA
08/2020
1CytokinesIBA
02/2020
1AdiponectinIBA
02/2020
1Cadherins (E-Cadherin)IBA
01/2020
1Cyclophilins (Cyclophilin)IBA
01/2020
1HydrogelsIBA
12/2018
1Histone Deacetylase InhibitorsIBA
02/2017
1Butyric Acid (Butanoic Acid)IBA
02/2017
1Bone Density Conservation AgentsIBA
11/2016
1AntiemeticsIBA
03/2016

Therapy/Procedure

14Therapeutics
07/2021 - 04/2005
7Drug Therapy (Chemotherapy)
01/2022 - 10/2012
6Radiotherapy
07/2021 - 10/2012
1Myotomy
01/2022
1Length of Stay
01/2022
1Osteotomy
01/2022
1Liver Transplantation
01/2022
1Traction
11/2021
1Immunotherapy
07/2021
1Kyphoplasty
01/2021
1Postoperative Care
03/2016